新华医疗
(600587)
| 流通市值：77.53亿 | | | 总市值：77.53亿 |
| 流通股本：6.07亿 | | | 总股本：6.07亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,014,677,496.29 | 3,104,377,572.42 | 3,110,821,529.99 | 3,094,951,280.75 |
| 应收票据及应收账款 | 2,465,498,272.04 | 2,468,564,406.97 | 2,061,067,487.72 | 2,091,079,035.69 |
| 其中：应收票据 | 241,998,631.41 | 151,735,817.05 | 90,312,415.68 | 178,933,478.35 |
| 应收账款 | 2,223,499,640.63 | 2,316,828,589.92 | 1,970,755,072.04 | 1,912,145,557.34 |
| 应收款项融资 | 55,660,328.53 | 79,206,293.98 | 44,979,248.18 | 65,187,140.55 |
| 预付款项 | 259,049,637.31 | 250,744,843.66 | 245,267,499.76 | 213,474,479.72 |
| 其他应收款合计 | 339,981,406.98 | 346,714,989.41 | 363,771,943.52 | 327,466,980.99 |
| 其中:应收利息 | 909,910.36 | 909,910.36 | 909,910.36 | 909,910.36 |
| 存货 | 2,717,906,709.8 | 2,643,667,053.13 | 2,790,860,151.99 | 2,903,246,965.28 |
| 合同资产 | 145,378,167.51 | 144,193,429.13 | 137,407,687.07 | 138,963,585.54 |
| 一年内到期的非流动资产 | 21,599,882.13 | 22,947,947.33 | 16,479,877.94 | 15,649,816.58 |
| 其他流动资产 | 53,148,057.47 | 47,137,750.2 | 48,703,909.87 | 43,567,543.72 |
| 流动资产合计 | 9,072,899,958.06 | 9,107,554,286.23 | 8,819,359,336.04 | 8,893,586,828.82 |
| 非流动资产: | | | | |
| 长期应收款 | 3,341,138.92 | 3,510,118.41 | 11,616,528.43 | 12,927,063.27 |
| 长期股权投资 | 1,228,048,095.71 | 1,233,457,200.19 | 1,248,919,179.17 | 1,272,339,852.75 |
| 其他权益工具投资 | 4,610,015.86 | 4,610,015.86 | 4,610,015.86 | 4,610,015.86 |
| 其他非流动金融资产 | 84,018,031.48 | 86,053,874.39 | 87,969,192.24 | 90,293,916.26 |
| 投资性房地产 | 300,697,293.5 | 305,438,388.12 | 305,645,551.53 | 309,381,731.67 |
| 固定资产 | 3,107,269,469.61 | 3,135,602,923.69 | 3,168,587,839.28 | 3,185,530,808.12 |
| 在建工程 | 39,024,594.85 | 30,416,685.35 | 25,438,970.69 | 21,066,437.86 |
| 使用权资产 | 53,283,590.6 | 56,059,714.56 | 53,804,226.58 | 62,768,173.74 |
| 无形资产 | 435,868,278.88 | 439,730,724.77 | 444,182,632.89 | 447,202,493.38 |
| 商誉 | 242,040,699.93 | 242,040,699.93 | 242,040,699.93 | 242,040,699.93 |
| 长期待摊费用 | 136,637,214.42 | 123,854,600.9 | 124,523,073.78 | 123,538,728.45 |
| 递延所得税资产 | 127,756,209.59 | 128,683,706.58 | 125,609,383.64 | 129,354,456 |
| 其他非流动资产 | 46,346,155.18 | 47,181,691.28 | 45,981,291.26 | 24,929,049.06 |
| 非流动资产合计 | 5,808,940,788.53 | 5,836,640,344.03 | 5,888,928,585.28 | 5,925,983,426.35 |
| 资产总计 | 14,881,840,746.59 | 14,944,194,630.26 | 14,708,287,921.32 | 14,819,570,255.17 |
| 流动负债: | | | | |
| 短期借款 | 814,668,252.03 | 835,441,802.39 | 919,086,632.7 | 925,138,695.04 |
| 应付票据及应付账款 | 2,739,040,196.41 | 2,794,085,262.55 | 2,695,616,952.61 | 2,531,836,577.4 |
| 其中：应付票据 | 407,966,677.71 | 314,493,711.77 | 277,226,811.95 | 194,070,287.86 |
| 应付账款 | 2,331,073,518.7 | 2,479,591,550.78 | 2,418,390,140.66 | 2,337,766,289.54 |
| 合同负债 | 1,351,837,641.87 | 1,417,554,146.51 | 1,471,247,079 | 1,649,176,122.93 |
| 应付职工薪酬 | 219,911,840.53 | 228,337,474.5 | 186,543,377.92 | 321,209,302.21 |
| 应交税费 | 62,536,358.2 | 147,536,717.19 | 84,458,016.67 | 87,688,856.43 |
| 其他应付款合计 | 570,804,880.76 | 576,943,096.85 | 540,906,662.16 | 556,535,130.27 |
| 应付股利 | 4,362,731.29 | 5,162,731.29 | 3,962,731.29 | 4,362,731.29 |
| 一年内到期的非流动负债 | 73,799,379.38 | 63,662,300.66 | 58,538,055.95 | 120,366,479.76 |
| 其他流动负债 | 417,337,339.83 | 332,598,316.24 | 289,014,615.25 | 355,534,676.12 |
| 流动负债合计 | 6,249,935,889.01 | 6,396,159,116.89 | 6,245,411,392.26 | 6,547,485,840.16 |
| 非流动负债: | | | | |
| 长期借款 | 150,440,804.61 | 131,474,445.92 | 123,650,486.88 | 90,565,315.86 |
| 租赁负债 | 42,452,374.48 | 47,480,863.67 | 59,054,465.78 | 48,823,016.04 |
| 长期应付款 | 803,334.77 | 1,052,859.21 | 1,458,947.53 | 1,730,337.76 |
| 递延收益 | 82,231,054.94 | 82,613,880.25 | 81,494,854.03 | 77,915,480.36 |
| 递延所得税负债 | 99,182,708.76 | 98,142,771.34 | 97,255,706.1 | 95,854,356.92 |
| 非流动负债合计 | 375,110,277.56 | 360,764,820.39 | 362,914,460.32 | 314,888,506.94 |
| 负债合计 | 6,625,046,166.57 | 6,756,923,937.28 | 6,608,325,852.58 | 6,862,374,347.1 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 606,644,549 | 606,644,549 | 606,644,549 | 606,677,919 |
| 其他权益工具 | -73,577,993.14 | -73,577,993.14 | -73,577,993.14 | -73,577,993.14 |
| 资本公积 | 2,489,991,417.86 | 2,489,901,072.81 | 2,497,153,323.55 | 2,497,371,897.05 |
| 减:库存股 | - | - | - | 17,743,221.78 |
| 其他综合收益 | -7,384,135.53 | -7,384,135.53 | 2,847,449.87 | 2,847,449.87 |
| 专项储备 | 65,035,643.54 | 61,738,884.93 | 58,934,089.57 | 55,382,264.11 |
| 盈余公积 | 448,513,450.61 | 448,513,450.61 | 448,513,450.61 | 448,513,450.61 |
| 未分配利润 | 4,414,641,026 | 4,339,183,459.56 | 4,238,627,769.6 | 4,114,570,738.68 |
| 归属于母公司股东权益合计 | 7,943,863,958.34 | 7,865,019,288.24 | 7,779,142,639.06 | 7,634,042,504.4 |
| 少数股东权益 | 312,930,621.68 | 322,251,404.74 | 320,819,429.68 | 323,153,403.67 |
| 股东权益合计 | 8,256,794,580.02 | 8,187,270,692.98 | 8,099,962,068.74 | 7,957,195,908.07 |
| 负债和股东权益合计 | 14,881,840,746.59 | 14,944,194,630.26 | 14,708,287,921.32 | 14,819,570,255.17 |
| 公告日期 | 2026-10-31 | 2026-08-29 | 2026-04-30 | 2026-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |